Current Pharmaceutical Design

William A. Banks  
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108


Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis

Author(s): Elisabet Rosas, Igor Sobenin, Alexander Orekhov, Elazer R. Edelman and Mercedes Balcells

Affiliation: Massachusetts Institute of Technology, Harvard-MIT Biomedical Engineering Center, 77 Massachusetts Avenue, E25-438, Cambridge, MA 02139, US.


Atherosclerosis is the leading cause of death in the Western World and has been for decades a field of intense research. Yet, while there is a rich and diverse literature describing in detail the players and mechanisms involved in this complex disease in cell and animal models, we remain today with virtually no reliable markers for early diagnosis and targeted treatments options. This review is centered upon the latter. We summarize the latest studies focused on detecting endothelial dysfunction during the early stages of atherosclerosis, when the disease is asymptomatic and describe strategies recently proposed to image and target advanced plaque.

Keywords: Atherosclerosis, biomarkers, endothelial cells, receptors, early diagnosis, direct targeting.

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [5897 - 5903]
Pages: 7
DOI: 10.2174/1381612811319330010
Price: $58